Modus Operandi

» cancer, immunology and disease/medicine

Most Recent

image: Tumor-Shrinking Triple-Helices

Tumor-Shrinking Triple-Helices

By | April 1, 2016

A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.

0 Comments

image: Bursting Cancer’s Bubble

Bursting Cancer’s Bubble

By | April 1, 2015

A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.

3 Comments

image: Bespoke Cell Jackets

Bespoke Cell Jackets

By | December 1, 2014

A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.

0 Comments

image: Exit Strategy

Exit Strategy

By | January 1, 2014

A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.

0 Comments

image: BRET Meets FRET

BRET Meets FRET

By | May 1, 2013

A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.

0 Comments

image: Mimicking Mussels

Mimicking Mussels

By | April 1, 2013

A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.

1 Comment

image: Dynamic Delivery

Dynamic Delivery

By | July 1, 2012

A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.

0 Comments

image: A Brighter Beacon

A Brighter Beacon

By | April 1, 2012

A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.

0 Comments

image: Delivering Silence

Delivering Silence

By | March 1, 2012

A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.

0 Comments

image: Switching the Bait

Switching the Bait

By | February 1, 2012

A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.

6 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech